Physician

Matthew Burns Cotant, M.D.

According to 2025 Medicare claims, Matthew Cotant, M.D. (NPI: 1003930215) practices hematology/oncology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is MICHIGAN HEALTHCARE PROFESSIONALS PC (NPI: 1295023547; TIN: 451674932) and primary practice location at 48073-9998. Cotant is affiliated with the Honest MSSP of Michigan LLC (ACO ID: A5616) and Honest ACO of Michigan LLC (ACO ID: D0236), participating under both the MSSP and REACH models.

Cotant's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 679 traditional Medicare patients, billed 135,293 HCPCS/CPT codes, and received $2,061,931 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,956 prescription claims across 332 beneficiaries totaling $3,621,181 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 24 claims. Open Payments data shows 160 records totaling $3,993. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,637,156 and ending at $2,061,931. Concurrently, Part D prescription costs have risen steadily, from $1,639,199 to $3,621,181. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $11,817 to $1,360.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	724	155,074	$1,637,156
2016	753	176,532	$2,176,060
2017	811	195,612	$2,707,716
2018	681	133,937	$2,064,072
2019	715	177,431	$2,123,669
2020	591	142,399	$2,144,374
2021	613	187,476	$3,119,999
2022	683	192,492	$2,395,870
2023	644	164,164	$2,313,731
2024	679	135,293	$2,061,931

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	306	1,644	$1,639,199
2016	318	1,815	$2,714,064
2017	296	1,716	$2,260,920
2018	290	1,773	$3,156,456
2019	335	2,064	$3,413,507
2020	306	2,049	$3,668,455
2021	327	2,059	$3,998,806
2022	328	2,000	$3,676,427
2023	307	1,694	$2,483,633
2024	332	1,956	$3,621,181

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	28	154	$41,127
2016	N/R	79	$15,380
2017	N/R	15	$8,600
2018	N/R	14	$4,059
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	50	$1,447
2023	N/R	41	$2,394
2024	N/R	24	$1,209

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	273	547	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	214	406	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	306	787	$13
36415	Insertion of needle into vein for collection of blood sample	501	1,295	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	484	1,244	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	43	1,290	$626,558
Cabometyx	Cabozantinib S-Malate	21	630	$519,925
Lenvima	Lenvatinib Mesylate	19	570	$448,637
Lenalidomide	Lenalidomide	31	847	$358,449
Jaypirca	Pirtobrutinib	16	480	$322,654

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$836
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$373

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	160	$3,993	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew Burns Cotant, M.D.?

Tedicare shows public-source Medicare data for Matthew Burns Cotant, M.D. (NPI 1003930215), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew Burns Cotant, M.D. have ACO affiliation data?

Matthew Burns Cotant, M.D. is shown with ACO affiliation data for Honest MSSP of Michigan LLC (MSSP, ACO ID A5616) and Honest ACO of Michigan LLC (REACH, ACO ID D0236).

What billing organization is linked to Matthew Burns Cotant, M.D.?

Matthew Burns Cotant, M.D. is linked to MICHIGAN HEALTHCARE PROFESSIONALS PC (billing NPI 1295023547) in the available physician profile data.

Does Matthew Burns Cotant, M.D. have Open Payments data?

Matthew Burns Cotant, M.D. has 160 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.